Information  X 
Enter a valid email address

F&C Investment Trust (FCIT)

  Print          Annual reports

Thursday 02 December, 2021

F&C Investment Trust

Issue of Debt

RNS Number : 4034U
F&C Investment Trust PLC
02 December 2021









LEI: 213800W6B18ZHTNG7371


F&C Investment Trust plc (the 'Company') has agreed to issue fixed rate senior unsecured private placement notes in tranches of (i) 2037, £50m principal, at a coupon of 2.06%, (ii) 2056, £45m principal, at a coupon of 1.96%, and (iii) 2061, £45m principal, at a coupon of 1.87%, (the 'Notes'). The funding date for the Notes is expected to be 1 March 2022.


The purpose of this transaction is to obtain a mix of medium and long-dated fixed rate denominated financing, which is unsecured, at pricing levels that the Company considers to be highly attractive. This funding will also improve further the maturity profile of the Company's borrowings. There has been no change in the Company's policy on gearing.


Net proceeds from the sale of the Notes will be used for the refinancing of existing indebtedness, investment and other general corporate purposes. The weighted average interest payable on the newly issued Notes will be under 2.0%. 



For further information please contact:


Paul Niven: 020 7011 4385 

BMO Investment Business Limited



2 December 2021






The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the 'Act') and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Act. This notice is for information only, does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t